JP2009529559A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529559A5
JP2009529559A5 JP2008558724A JP2008558724A JP2009529559A5 JP 2009529559 A5 JP2009529559 A5 JP 2009529559A5 JP 2008558724 A JP2008558724 A JP 2008558724A JP 2008558724 A JP2008558724 A JP 2008558724A JP 2009529559 A5 JP2009529559 A5 JP 2009529559A5
Authority
JP
Japan
Prior art keywords
vitamin
composition according
magnesium
dosage unit
blueberry extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008558724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529559A (ja
Filing date
Publication date
Priority claimed from DE102006011922A external-priority patent/DE102006011922A1/de
Application filed filed Critical
Publication of JP2009529559A publication Critical patent/JP2009529559A/ja
Publication of JP2009529559A5 publication Critical patent/JP2009529559A5/ja
Pending legal-status Critical Current

Links

JP2008558724A 2006-03-15 2007-03-15 耳鳴り治療用製剤 Pending JP2009529559A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006011922A DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus
PCT/EP2007/002294 WO2007104566A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus

Publications (2)

Publication Number Publication Date
JP2009529559A JP2009529559A (ja) 2009-08-20
JP2009529559A5 true JP2009529559A5 (enExample) 2010-06-24

Family

ID=38229816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558724A Pending JP2009529559A (ja) 2006-03-15 2007-03-15 耳鳴り治療用製剤

Country Status (9)

Country Link
US (2) US20090220592A1 (enExample)
EP (1) EP1993578A1 (enExample)
JP (1) JP2009529559A (enExample)
AU (1) AU2007224668A1 (enExample)
CA (1) CA2646528A1 (enExample)
DE (1) DE102006011922A1 (enExample)
EA (1) EA013457B1 (enExample)
IL (1) IL194066A0 (enExample)
WO (1) WO2007104566A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
CA3094903A1 (en) * 2018-03-23 2019-09-26 Vanessa Research, Inc. Compositions and methods for treating diarrheal diseases
KR102175201B1 (ko) * 2019-09-06 2020-11-06 (주)아이엠디팜 빌베리 추출물을 유효성분으로 함유하는 감각신경성 난청 예방 또는 치료용 조성물
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6524619B2 (en) * 2000-01-27 2003-02-25 Chronorx, Inc. Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus
JP2002308752A (ja) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd 皮膚外用剤
DE202004004618U1 (de) * 2004-03-24 2004-05-19 Aiones The Brainpower Company Blaubeerextrakt
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe
JP2005306882A (ja) * 2005-06-08 2005-11-04 Alan Smith Richard 感情的不安定の治療のための医薬の製造に有用な組成物

Similar Documents

Publication Publication Date Title
ATE543489T1 (de) Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
JP2013511507A5 (enExample)
FI3435996T3 (fi) Elafibranori käytettäväksi primaarisen biliaarisen kolangiitin hoidossa
JP2015508082A5 (enExample)
HK1247835A1 (zh) 甲状旁腺功能减退症的治疗
WO2009051840A3 (en) Compositions and methods for reducing hepatotoxicity associated with drug administration
JP2013509395A5 (enExample)
JP2014198723A5 (enExample)
JP2014205701A5 (enExample)
WO2015034678A3 (en) Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
JP2009529559A5 (enExample)
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
UA102885C2 (ru) Таблетка для орального введения, которая содержит тамсулозин и солифенацин
JP2015537009A5 (enExample)
MX2013001637A (es) Composiciones farmaceuticas de liberacion controlada oral de blonanserina.
ATE488225T1 (de) Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff
WO2008104852A3 (en) Pharmaceutical compositions comprising adsorbate of fenofibrate
WO2013026558A3 (de) Kombinationstherapeutikum
JP2008516004A5 (enExample)
NZ719000A (en) Slow-release solid oral compositions
WO2013098268A3 (en) Tablets and dry-coated agents
WO2012063005A3 (fr) Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
JP2009505991A5 (enExample)
WO2012067482A3 (es) COMPOSICIÓN FARMACÉUTICA ADAPTADA PARA ADMINISTRARSE ORALMENTE Y PROCESO PARA SU PREPARACIÓN, PARA PREVENCIÓN Y TRATAMIENTO DEL SÍNDROME DE INTESTINO IRRITABLE, A BASE DE UN MODIFICADOR DE LA MOTILIDAD INTESTINAL Y α-D-GALAGTOSIDASA
JP2012041314A5 (enExample)